Evidence map›Paper›PMID 41263104›Full record

ArticleNucleic acids research2026

FireProtDB 2.0: large-scale manually curated database of the protein stability data.

Milos Musil, Simeon Borko, Joan Planas-Iglesias, David Lacko, Monika Rosinska, Petr Kabourek, Lígia O Martins, Mateusz Tataruch, Jiri Damborsky, Stanislav Mazurenko and 1 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Milos MusilLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Masaryk University, 625 00, Brno, Czech Republic.
Simeon BorkoLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Masaryk University, 625 00, Brno, Czech Republic.
Joan Planas-IglesiasLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Masaryk University, 625 00, Brno, Czech Republic.
David LackoLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Masaryk University, 625 00, Brno, Czech Republic.
Monika RosinskaInternational Clinical Research Centre, St. Anne's University Hospital Brno, 602 00, Brno, Czech Republic.
Petr KabourekLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Masaryk University, 625 00, Brno, Czech Republic.
Lígia O MartinsInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, 2780-157, Oeiras, Portugal.
Mateusz TataruchJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, PL-30239, Krakow, Poland.
Jiri DamborskyLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Masaryk University, 625 00, Brno, Czech Republic.ORCID 0000-0002-7848-8216
Stanislav MazurenkoLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Masaryk University, 625 00, Brno, Czech Republic.ORCID 0000-0003-3659-4819
David BednarLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Masaryk University, 625 00, Brno, Czech Republic.ORCID 0000-0002-6803-0340

Funding

Brno University of Technology FIT-S-23-8209COST Action COZYME CA21162Czech Ministry of Education, Youth and Sports, and Grant Agency 25-18233Me-INFRAELIXIR 90254ELIXIR LM2023055ELIXIR LM2023069European Union Centre of Excellence CLARA 101136607European Union's Horizon 2020 research and innovation programme 857560 TEAMINGRECETOX
6 · The paper itself

Abstract

Thermostable proteins are crucial in numerous biomedical and biotechnological applications. However, naturally occurring proteins have evolved to function in mild conditions, and laboratory experiments aiming at improving protein stability have proven laborious and expensive. Computational methods overcome this issue by providing a cheap and scalable alternative. Despite significant progress, their reliability is still hindered by the availability of high-quality data. FireProtDB 2.0 (http://loschmidt.chemi.muni.cz/fireprotdb) is a large-scale database aggregating stability data from multiple sources. The second version builds upon its predecessor, retaining its original functionality while introducing a new approach to data storage and maintenance. The new scheme enables the introduction of both absolute and relative data types connected with measurements of wild-types, mutants, protein domains, and de novo designed proteins. Furthermore, while the original database was limited to single-point mutations, more complex data such as insertions, deletions, and multiple-point mutations are now available. As a result, the inclusion of large-scale mutagenesis has increased the size of the database from 16 000 to almost 5 500 000 experiments. Moreover, the updated abstract scheme is fully expandable with any new measurements and annotations without the need for any restructuring. Finally, the tracking of history together with fixed identifiers is in accordance with the FAIR principles.

Indexed as

Databases, ProteinProteinsComputational BiologyData CurationInternetProtein StabilitySoftwareProteins

Identifiers

PMID41263104
PMCPMC12807726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.